hydroxychloroquine for COVID-19 - live meta-analysis of clinical studies

Study explorer (study characteristics and results) method abbreviations pdf xlsx

display ongoing studies
Study	Ref.	RCT OBS RCT + OBS	studied treatment	control treatment	patients	study risk of bias	sample sizes	Results	deaths E	clinical improvement E	death or ventilation E
COVID 19 all comers meta-analysis
ChiCTR2000030054-HCQ (Chen), 2020 ChiCTR2000030054		RCT	hydroxychloroquine	standard of care	COVID 19 all comers	high	18/12	inconclusive
Gautret et al., 2020		NRa	hydroxychloroquine	control	COVID 19 all comers	serious	20/16	suggested

PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).

Study explorer (study characteristics and results) method abbreviations pdf xlsx

COVID 19 all comers meta-analysis